{"name":"Celosia Therapeutics Pty Ltd","slug":"celosia-therapeutics-pty-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"AAV9 Gene therapy","genericName":"AAV9 Gene therapy","slug":"aav9-gene-therapy","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"AAV9 Gene therapy","genericName":"AAV9 Gene therapy","slug":"aav9-gene-therapy","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxOVFJvOE9WenR6NzB2dGNYR0xtV3BpVWpxX2FEZ0VVcXFRaW0wQlAxckdfZm9QeWtTWTNHdmtVc0hVT3kzWUdKeXhuRm1NSXpaalo0WUpnMFNHbXRqR2MyZDZXblJpMFp2aS1BZTVCZk9Ea2tRZ0NqcmpndzBPUlhhemE3TFZHejcxZGRxT2V3MkNSbVpzd2FZNU52UEZGTXhjd0tQR29ILXkwRU5fODE4?oc=5","date":"2026-03-24","type":"trial","source":"PharmaDispatch","summary":"First patient treated in Australian trial targeting core ALS disease mechanism - PharmaDispatch","headline":"First patient treated in Australian trial targeting core ALS disease mechanism","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQRzc0WUhydlJrMFp2TTNuMjlPRTJZRTZodUsyUUVCTFFxMzlEbjFubVhBUWYyWGpkTExJenFYalRUVHlrbm9LNHpoRVdRblItbmtXVDNmc1J6T1J0SnhKbW1SVklZcjRwTjRNR003V0p3SHNyZlV6Z1hGbW5fYjVWQmVTbDVJQUQycFFTb0RQOHFUQlZIdVRjdkh1SXZhV1F6QUgtVTZLZks?oc=5","date":"2025-01-03","type":"pipeline","source":"BioWorld News","summary":"Australia’s Celosia heads toward clinic with gene therapy for ALS - BioWorld News","headline":"Australia’s Celosia heads toward clinic with gene therapy for ALS","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxOd0Z4RzFGQ21TeWNpdWNKMENoVTA0am5DSVhMdXFJalB2SFA0QV9sWmxwSHp5LXoyQndISWtlLXVGLVFrUktfNXlQel9CVFhvajhIRENIWEctVGNOZ1UzUmJlcTNLbGhhby1YelhBTVVDOGZyOFJYbHB4LXZNZ1FiUmUyWG5TZXgtdnlqandSLTRFdkpuU3Rnd0FPbjFmbXpxTUJoelMyV0JxaGlobzNsY05WRUR0MU5MSGp2bG9jUTM?oc=5","date":"2024-11-28","type":"pipeline","source":"Biotech Dispatch","summary":"Macquarie University spinout secures landmark funding for breakthrough ALS gene therapy - Biotech Dispatch","headline":"Macquarie University spinout secures landmark funding for breakthrough ALS gene therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPSVp6b3FiMk9UZlV1RjBwYXF6WU14Z1Y5R0p2eFBhUzRsTVJUdl96a21XUjRwNEpzMnU3SlFfMTU4MmVBcVJSczlscl9SNWxGZ2tfLU0tdzRqUC15enBMTHpqdGd2NW5CWWlZQ0thbmVZalJjbU1wSTNZdW95cHZpcWtoUldiYkRvQTV0VzNXZ0pVNnVvb1pTdF9uR29pQQ?oc=5","date":"2024-11-28","type":"pipeline","source":"Health Services Daily","summary":"Biotech secures landmark $16.75m for ALS gene therapy - Health Services Daily","headline":"Biotech secures landmark $16.75m for ALS gene therapy","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}